Cochlear Limited, which creates implantable hearing devices, has taken a technological leap forward with a device that syncs up with various Apple products. The Nucleus 7 Sound Processor, which was ...

LONE TREE, Colo., July 8, 2025 /PRNewswire/ -- Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, today announced the U.S Food and Drug Administration (FDA) approval of ...

The Nucleus 8 Sound Processor is the world's first cochlear implant sound processor ready for Bluetooth LE Audio technology Experience the full interactive ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Study Overview: Cochlear Limited is ...

Cochlear Limited ($CHEOF) announced an update on their ongoing clinical study. Study Overview: Cochlear Limited has recently completed an early ...

When the parts of the ear that transmit sound to the auditory nerve are damaged—as they often are in the severely deaf—a hearing aid that merely amplifies sound offers little assistance. Today, more ...

The FDA has approved hearing implant maker Cochlear Limited’s submission for a new remote feature that would allow specialists to perform follow-up programming on a patient’s cochlear implant remotely ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Cochlear Limited is spearheading a ...

CHICAGO (CN) - In a federal class action, a father claims Cochlear Limited's ear implants failed inside his young daughter one month before the FDA recalled them for a manufacturing defect. Wyly Wade ...

WEYBRIDGE, United Kingdom--(BUSINESS WIRE)--Cochlear Limited (ASX: COH), the global leader in implantable hearing solutions, has today announced the release of the Nucleus ® Smart App for Android ™, ...

MONTPELLIER, France & SYDNEY--(BUSINESS WIRE)--Regulatory News: Sensorion (FR0012596468 – ALSEN) a biotech company pioneering novel treatments for inner ear diseases, and Cochlear Limited (ASX: COH), ...